George W LeMaitre sold $8.6M of LMAT
Chairman and CEO at LEMAITRE VASCULAR INC. 100,000 shares at an average of $85.57, traded May 16, 2025, filed May 20, 2025.
Score components
- +25RoleCEO
- +25Trade size$8.6M at market
- 0Share of holdings soldSold 5.3% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.6%, 3m +12.5%, 6m +2.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-25-017883, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 16, 2025 | SOpen-market sale Common Stock | -18,733 | $84.77 | $1.6M | 1,873,651 | May 20, 2025 |
| May 19, 2025 | SOpen-market sale Common Stock | -71,168 | $85.86 | $6.1M | 1,802,483 | May 20, 2025 |
| May 19, 2025 | SOpen-market sale Common Stock | -5,700 | $84.94 | $484k | 1,796,783 | May 20, 2025 |
| May 20, 2025 | MOption exercise Common Stock | +5,792 | $35.48 | $206k | 1,802,575 | May 20, 2025 |
| May 20, 2025 | MOption exercise Common Stock | +7,836 | $37.29 | $292k | 1,810,411 | May 20, 2025 |
| May 20, 2025 | MOption exercise Common Stock | +7,734 | $48.60 | $376k | 1,818,145 | May 20, 2025 |
| May 20, 2025 | MOption exercise Common Stock | +7,075 | $47.19 | $334k | 1,825,220 | May 20, 2025 |
| May 20, 2025 | MOption exercise Common Stock | +6,182 | $54.65 | $338k | 1,831,402 | May 20, 2025 |
| May 20, 2025 | SOpen-market sale Common Stock | -3,300 | $85.24 | $281k | 1,828,102 | May 20, 2025 |
| May 20, 2025 | SOpen-market sale Common Stock | -1,099 | $84.69 | $93k | 1,827,003 | May 20, 2025 |
| May 20, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -5,792 | $0.00 | $0 | 0 | May 20, 2025 |
| May 20, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -7,836 | $0.00 | $0 | 7,836 | May 20, 2025 |
| May 20, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -7,734 | $0.00 | $0 | 7,733 | May 20, 2025 |
| May 20, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -7,075 | $0.00 | $0 | 16,269 | May 20, 2025 |
| May 20, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -6,182 | $0.00 | $0 | 20,373 | May 20, 2025 |
Related signals
Other insiders at LEMAITRE VASCULAR INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | LEMAITRE VASCULAR INC | Lawrence J Jasinski director | $434k 3,943 shares | -46% | |
| 54Moderate | LEMAITRE VASCULAR INC | Trent G Kamke Senior V. P., Operations | $313k 2,928 shares | -44% | |
| 54Moderate | LEMAITRE VASCULAR INC | Bridget A Ross director | $560k 5,044 shares | -56% | |
| 65Notable | LEMAITRE VASCULAR INC | George W LeMaitre Chairman and CEO | $5.0M 46,481 shares | -3% | |
| 39Weak | LEMAITRE VASCULAR INC | Trent G Kamke Senior V. P., Operations | $285k 2,625 shares | -28% | |
| 55Moderate | LEMAITRE VASCULAR INC | David B Roberts President and Director | $357k 3,312 shares | -18% | |
| 30Weak | LEMAITRE VASCULAR INC | Trent G Kamke Senior V. P., Operations | $115k 1,044 shares | -14% | |
| 35Weak | LEMAITRE VASCULAR INC | George W LeMaitre Chairman and CEO | $22M 205,930 shares | -12% | |
| 54Moderate | LEMAITRE VASCULAR INC | David B Roberts President and Director | $904k 8,464 shares | -32% | |
| 44Moderate | LEMAITRE VASCULAR INC | Lawrence J Jasinski director | $91k 976 shares | -17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.